Rheumatic fever in the 21st century

Clinical Infectious Diseases

Volumn 33, Issue 6, 2001, Pages 806-814

  Stollerman, G H ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; PENICILLIN G;

ACUTE GLOMERULONEPHRITIS; BACTERIAL COLONIZATION; BACTERIAL MEMBRANE; BACTERIAL VIRULENCE; CROSS REACTION; HUMAN; PHARYNGITIS; PREVALENCE; PRIORITY JOURNAL; REVIEW; RHEUMATIC FEVER; STRAIN DIFFERENCE; STREPTOCOCCUS GROUP A;

ARTHRITIS, REACTIVE; BACTERIAL VACCINES; CHOREATIC DISORDERS; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; MYOCARDITIS; PHARYNGITIS; RHEUMATIC FEVER; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; UNITED STATES; VIRULENCE;

EID: 0035884736     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/322665     Document Type: Review

References (66)

1. Rheumatic fever
2. The relation of antibody response to rheumatic fever
3. The antibody responses in man to infection with different serotypes of group A streptococci
4. Rheumatic heart disease in developing countries: The consequence of inadequate prevention
5. Studies on the immune response of the rheumatic subject and its relationship to activity of the rheumatic process. IV. Characteristics of strains of hemolytic streptococci, effective and non-effective in initiating rheumatic activity
6. Acute glomerulonephritis: The significance of the variations in the incidence of the disease
7. Variable epidemiology of streptococcal disease and the changing pattern of rheumatic fever
8. Medical progress: Differences between streptococcal infections of the throat and of the skin
9. Contrasting epidemiology of acute rheumatic fever and acute glomerulonephritis: Nature of the antecedent streptococcal infection
10. The changing face of rheumatic fever in the 20th century
11. The concept of rheumatogenic and non-rheumatogenic group A streptococci
12. Variation occurring in group A streptococci during human infection: Progressive loss of M substance correlated with increasing susceptibility to bacteriostasis
13. The relative importance of the capsule and the M antigen in determining colony form of group A streptococci
14. Epithelial cell binding of group A streptococci by lipoteichoic acid on fimbriae denuded of M protein
15. Roles of integrins and fibronectin in the entry of Streptococcus pyogenes into cells via protein F1
16. Streptococcus pyogenes serotype M1 encodes multiple pathways for entry into human epithelial cells
17. Prevalence of internalization-associated gene, prtF1, among persisting group-A streptococcus strains isolated from asymptomatic carriers
18. Mutation in csrR global regulator reduces Streptococcus pyogenes internalization
19. Characterization of a mouse-passaged highly encapsulated variant of group A streptococcus in vitro and in vivo studies
20. Molecular characterization of hasA from an operon required for hyaluronic acid synthesis in group A streptococci
21. Molecular analysis of the role of the group A streptococcal cysteine proteinase, hyaluronic acid, capsule and M protein in a murine model of human invasive soft-tissue infections
22. A response regulator that represses transcription of several virulence operons in the group A streptococcus
23. Treatment of group A streptococcal pharyngitis
24. Protection of a military population from rheumatic fever
25. Resurgence of acute rheumatic fever in the intermountain area of the United States
26. Global assessment of rheumatic fever and rheumatic heart disease at the close of the century
27. Acute rheumatic fever: Utah
28. Immunologic and clinical correlations in rheumatic fever and rheumatic heart disease
29. Hemolytic streptococcus gangrene
30. Contrasting molecular epidemiology of group A streptococci causing tropical and nontropical infections of skin and throat
31. Tropical acute rheumatic fever and associated streptococcal infections compared with concurrent acute glomerulonephritis
32. Purification and properties of M protein extracted from group A streptococci with pepsin: Covalent structure of the amino terminal region of type 24 M antigen
33. Human immune response to immunization with a structurally defined polypeptide fragment of streptococcal M protein
34. Group A streptococcal vaccines
35. Multivalent group A streptococcal vaccine designed to optimize the immunogenicity of six tandem M protein fragments
36. Structure, function and genetics of streptococcal M protein
37. Evidence for two distinct classes of streptococcal M-protein and their relationship to rheumatic fever
38. Serologic evidence for a class I group A streptococcal infection among rheumatic fever patients
39. Genetic correlates of throat and skin isolates of group A streptococci
40. Pathogenesis of group A streptococcal infections
41. Immunogenic and genetic factors in rheumatic fever
42. Update on complications of group A streptococcal infections
43. Presence of a non-HLA B cell antigen in rheumatic fever patients and their families as defined by a monoclonal antibody
44. Evaluation of secondary prophylactic schemes, based on benzathine penicillin G, for rheumatic fever in children
45. Three- versus four-week administration of benzathine penicillin G: Effects on incidence of streptococcal infections and recurrences of rheumatic fever
46. Treatment of acute streptococcal pharyngitis and prevention of rheumatic fever: A statement for health professionals
47. Rheumatic fever in children and adolescents: A long-term epidemiological study of subsequent prophylaxis, streptococcal infections, and clinical sequelae. IV. Relation of the rheumatic fever recurrence rate per streptococcal infection to the titers of streptococcal antibodies
48. Preventing the spread of antimicrobial resistance among bacterial respiratory pathogens in industrialized countries: The case for judicious antimicrobial use
49. Diagnosis and management of group A streptococcal pharyngitis: A practice guideline
50. Guidelines for the diagnosis of rheumatic fever. Jones Criteria, 1992 update
51. Group A streptococcal infections
52. Diagnosis of active carditis: The echos of change
53. Doppler echocardiography distinguishes between physiologic and pathologic "silent" mitral regurgitation in patients with rheumatic fever
54. Rheumatic fever
55. The rebound phenomenon in acute rheumatic fever. I. Incidence and significance
56. Poststreptococcal reactive arthritis
57. Poststreptococcal reactive arthritis: Clinical characteristics and association with HLA-DR alleles
58. Sydenham's chorea: A model for childhood autoimmune neuropsychiatric disorders
59. Neuropsychiatric aspects of Sydenham's chorea: A comprehensive review
60. Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood
61. A pilot study of penicillin prophylaxis for neuropsychiatric exacerbations triggered by streptococcal infections
62. Echocardiography for diagnosis and management of rheumatic fever
63. Echocardiographic evaluation of patients with acute rheumatic fever and rheumatic carditis
64. Does endomyocardial biopsy aid in the diagnosis of active rheumatic carditis?
65. The treatment of rheumatic carditis: A review and meta-analysis